Chugai Pharmaceutical Co (JP:4519) has released an update.
Chugai Pharmaceutical Co., Ltd. has announced corrections to its previously disclosed 2023 consolidated financial statements. The adjustments pertain to errors in the breakdown of operating segment information, particularly involving major customer data. Corrected figures for fiscal year 2023 have been released, with changes underlined in the updated documents.
For further insights into JP:4519 stock, check out TipRanks’ Stock Analysis page.
